Welch Group LLC increased its holdings in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 1.4% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 337,798 shares of the company's stock after buying an additional 4,725 shares during the quarter. Procter & Gamble comprises approximately 2.2% of Welch Group LLC's portfolio, making the stock its 24th biggest holding. Welch Group LLC's holdings in Procter & Gamble were worth $53,818,000 as of its most recent SEC filing.
Several other large investors have also recently added to or reduced their stakes in PG. Kingstone Capital Partners Texas LLC raised its holdings in shares of Procter & Gamble by 655,209.0% in the 2nd quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company's stock worth $11,832,680,000 after purchasing an additional 76,017,350 shares during the period. Nuveen LLC purchased a new position in shares of Procter & Gamble in the 1st quarter worth about $1,954,941,000. Price T Rowe Associates Inc. MD raised its holdings in shares of Procter & Gamble by 13.0% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company's stock worth $3,660,737,000 after purchasing an additional 2,466,308 shares during the period. Invesco Ltd. raised its holdings in shares of Procter & Gamble by 19.8% in the 1st quarter. Invesco Ltd. now owns 13,493,604 shares of the company's stock worth $2,299,580,000 after purchasing an additional 2,228,151 shares during the period. Finally, Valeo Financial Advisors LLC raised its holdings in shares of Procter & Gamble by 1,875.5% in the 2nd quarter. Valeo Financial Advisors LLC now owns 1,763,404 shares of the company's stock worth $280,946,000 after purchasing an additional 1,674,139 shares during the period. 65.77% of the stock is currently owned by hedge funds and other institutional investors.
Procter & Gamble Stock Performance
Shares of PG opened at $149.69 on Monday. Procter & Gamble Company has a 1 year low of $149.45 and a 1 year high of $180.43. The company has a market cap of $350.34 billion, a price-to-earnings ratio of 22.99, a price-to-earnings-growth ratio of 3.97 and a beta of 0.36. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.49 and a current ratio of 0.70. The firm has a fifty day moving average of $155.24 and a 200-day moving average of $159.41.
Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The company had revenue of $20.89 billion during the quarter, compared to analyst estimates of $20.79 billion. During the same quarter in the previous year, the firm posted $1.40 EPS. The firm's quarterly revenue was up 1.7% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, equities analysts anticipate that Procter & Gamble Company will post 6.91 earnings per share for the current year.
Insiders Place Their Bets
In other news, CEO Jon R. Moeller sold 11,684 shares of the company's stock in a transaction on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total value of $1,778,655.32. Following the completion of the sale, the chief executive officer owned 319,932 shares in the company, valued at $48,703,248.36. This represents a 3.52% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CEO Jennifer L. Davis sold 3,227 shares of the business's stock in a transaction on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total value of $491,246.21. Following the sale, the chief executive officer directly owned 61,764 shares in the company, valued at $9,402,333.72. This trade represents a 4.97% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 149,763 shares of company stock valued at $23,421,279. 0.20% of the stock is currently owned by insiders.
Wall Street Analysts Forecast Growth
Several equities research analysts recently commented on PG shares. Wells Fargo & Company dropped their target price on Procter & Gamble from $173.00 to $170.00 and set an "overweight" rating on the stock in a report on Thursday, September 25th. Berenberg Bank lifted their price objective on Procter & Gamble from $152.00 to $154.00 and gave the stock a "hold" rating in a report on Wednesday, September 17th. BNP Paribas Exane dropped their price objective on Procter & Gamble from $177.00 to $172.00 and set an "outperform" rating on the stock in a report on Tuesday, September 23rd. UBS Group dropped their price objective on Procter & Gamble from $180.00 to $176.00 and set a "buy" rating on the stock in a report on Wednesday. Finally, Evercore ISI restated an "in-line" rating and set a $170.00 price objective (down from $190.00) on shares of Procter & Gamble in a report on Monday, July 14th. Eleven investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to MarketBeat, Procter & Gamble has an average rating of "Moderate Buy" and a consensus target price of $172.21.
Get Our Latest Stock Analysis on PG
Procter & Gamble Company Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report